ann out, page-15

Hi all

I think you will find if you read all the previous Ann's that there were only some questions that needed to be answered for the FDA approval.....not more studies or tests

The latest Ann states in a paragraph.......""""

The primary objective of this study is to generate the necessary safety data to allow more progressive clinical assessment of CAVATAK? in a variety of cancer indications that are best targeted using a strategy of intravenous administration.

>>>>>""""""

It is all about the up and coming trials over the next 6 to 12 months if you take a peek at the new web site.....VLA has got in place a couple of new trials coming up for various other cancers.....

All good, if you all take the time to read all the Ann's you will see what is going on......oh and check out the new web site.....plenty of info and details about these new up and coming trials.....

Cheers